In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Breast cancer Nature Reviews Disease Primers

The impact of race and age on response to neoadjuvant therapy and

Racial disparities in breast cancer may have genetic factor - STAT

Pathologic Complete Response: Understanding the Subtleties - The

Recurrence-Free Survival Curve for Black and White Patients by

The impact of race and age on response to neoadjuvant therapy and

Non-BRCA Early-Onset Breast Cancer in Young Women

PDF) Racial disparity in distant recurrence-free survival in

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Pre-surgical Immunotherapy Benefits Are Independent of Race in

Cureus Retrospective Analysis of HER2+ Breast Cancer Outcomes at

Pursuing Progress, Precision, and Equity in Cancer Care